The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Short Bowel Syndrome-Global Market Insights and Sales Trends 2024
Synopsis
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The global Short Bowel Syndrome market size is expected to reach US$ 1362.1 million by 2029, growing at a CAGR of 17.2% from 2023 to 2029. The market is mainly driven by the significant applications of Short Bowel Syndrome in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Short Bowel Syndrome market. GLP-2, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Growth Hormone segment is estimated at % CAGR for the next seven-year period.
The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Short Bowel Syndrome, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Short Bowel Syndrome market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Short Bowel Syndrome market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Short Bowel Syndrome sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Short Bowel Syndrome covered in this report include Takeda, Merck, Emmaus Life Sciences, Nutrinia, GlyPharma Therapeutics, OxThera, Ardelyx, Sancilio & Company and Naia Pharmaceuticals, etc.
The global Short Bowel Syndrome market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
Zealand Pharma
Global Short Bowel Syndrome market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Short Bowel Syndrome market, Segment by Type:
GLP-2
Growth Hormone
Glutamine
Others
Global Short Bowel Syndrome market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Short Bowel Syndrome companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The global Short Bowel Syndrome market size is expected to reach US$ 1362.1 million by 2029, growing at a CAGR of 17.2% from 2023 to 2029. The market is mainly driven by the significant applications of Short Bowel Syndrome in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Short Bowel Syndrome market. GLP-2, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Growth Hormone segment is estimated at % CAGR for the next seven-year period.
The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Short Bowel Syndrome, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Short Bowel Syndrome market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Short Bowel Syndrome market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Short Bowel Syndrome sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Short Bowel Syndrome covered in this report include Takeda, Merck, Emmaus Life Sciences, Nutrinia, GlyPharma Therapeutics, OxThera, Ardelyx, Sancilio & Company and Naia Pharmaceuticals, etc.
The global Short Bowel Syndrome market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Takeda
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
Zealand Pharma
Global Short Bowel Syndrome market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Short Bowel Syndrome market, Segment by Type:
GLP-2
Growth Hormone
Glutamine
Others
Global Short Bowel Syndrome market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Short Bowel Syndrome companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Short Bowel Syndrome
1.1 Short Bowel Syndrome Market Overview
1.1.1 Short Bowel Syndrome Product Scope
1.1.2 Short Bowel Syndrome Market Status and Outlook
1.2 Global Short Bowel Syndrome Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Short Bowel Syndrome Market Size by Region (2018-2029)
1.4 Global Short Bowel Syndrome Historic Market Size by Region (2018-2023)
1.5 Global Short Bowel Syndrome Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Short Bowel Syndrome Market Size (2018-2029)
1.6.1 North America Short Bowel Syndrome Market Size (2018-2029)
1.6.2 Europe Short Bowel Syndrome Market Size (2018-2029)
1.6.3 Asia-Pacific Short Bowel Syndrome Market Size (2018-2029)
1.6.4 Latin America Short Bowel Syndrome Market Size (2018-2029)
1.6.5 Middle East & Africa Short Bowel Syndrome Market Size (2018-2029)
2 Short Bowel Syndrome Market by Type
2.1 Introduction
2.1.1 GLP-2
2.1.2 Growth Hormone
2.1.3 Glutamine
2.1.4 Others
2.2 Global Short Bowel Syndrome Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Short Bowel Syndrome Historic Market Size by Type (2018-2023)
2.2.2 Global Short Bowel Syndrome Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Short Bowel Syndrome Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Short Bowel Syndrome Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Short Bowel Syndrome Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Short Bowel Syndrome Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Short Bowel Syndrome Revenue Breakdown by Type (2018-2029)
3 Short Bowel Syndrome Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global Short Bowel Syndrome Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Short Bowel Syndrome Historic Market Size by Application (2018-2023)
3.2.2 Global Short Bowel Syndrome Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Short Bowel Syndrome Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Short Bowel Syndrome Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Short Bowel Syndrome Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Short Bowel Syndrome Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Short Bowel Syndrome Revenue Breakdown by Application (2018-2029)
4 Short Bowel Syndrome Competition Analysis by Players
4.1 Global Short Bowel Syndrome Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Short Bowel Syndrome as of 2022)
4.3 Date of Key Players Enter into Short Bowel Syndrome Market
4.4 Global Top Players Short Bowel Syndrome Headquarters and Area Served
4.5 Key Players Short Bowel Syndrome Product Solution and Service
4.6 Competitive Status
4.6.1 Short Bowel Syndrome Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Takeda
5.1.1 Takeda Profile
5.1.2 Takeda Main Business
5.1.3 Takeda Short Bowel Syndrome Products, Services and Solutions
5.1.4 Takeda Short Bowel Syndrome Revenue (US$ Million) & (2018-2023)
5.1.5 Takeda Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Short Bowel Syndrome Products, Services and Solutions
5.2.4 Merck Short Bowel Syndrome Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Emmaus Life Sciences
5.3.1 Emmaus Life Sciences Profile
5.3.2 Emmaus Life Sciences Main Business
5.3.3 Emmaus Life Sciences Short Bowel Syndrome Products, Services and Solutions
5.3.4 Emmaus Life Sciences Short Bowel Syndrome Revenue (US$ Million) & (2018-2023)
5.3.5 Nutrinia Recent Developments
5.4 Nutrinia
5.4.1 Nutrinia Profile
5.4.2 Nutrinia Main Business
5.4.3 Nutrinia Short Bowel Syndrome Products, Services and Solutions
5.4.4 Nutrinia Short Bowel Syndrome Revenue (US$ Million) & (2018-2023)
5.4.5 Nutrinia Recent Developments
5.5 GlyPharma Therapeutics
5.5.1 GlyPharma Therapeutics Profile
5.5.2 GlyPharma Therapeutics Main Business
5.5.3 GlyPharma Therapeutics Short Bowel Syndrome Products, Services and Solutions
5.5.4 GlyPharma Therapeutics Short Bowel Syndrome Revenue (US$ Million) & (2018-2023)
5.5.5 GlyPharma Therapeutics Recent Developments
5.6 OxThera
5.6.1 OxThera Profile
5.6.2 OxThera Main Business
5.6.3 OxThera Short Bowel Syndrome Products, Services and Solutions
5.6.4 OxThera Short Bowel Syndrome Revenue (US$ Million) & (2018-2023)
5.6.5 OxThera Recent Developments
5.7 Ardelyx
5.7.1 Ardelyx Profile
5.7.2 Ardelyx Main Business
5.7.3 Ardelyx Short Bowel Syndrome Products, Services and Solutions
5.7.4 Ardelyx Short Bowel Syndrome Revenue (US$ Million) & (2018-2023)
5.7.5 Ardelyx Recent Developments
5.8 Sancilio & Company
5.8.1 Sancilio & Company Profile
5.8.2 Sancilio & Company Main Business
5.8.3 Sancilio & Company Short Bowel Syndrome Products, Services and Solutions
5.8.4 Sancilio & Company Short Bowel Syndrome Revenue (US$ Million) & (2018-2023)
5.8.5 Sancilio & Company Recent Developments
5.9 Naia Pharmaceuticals
5.9.1 Naia Pharmaceuticals Profile
5.9.2 Naia Pharmaceuticals Main Business
5.9.3 Naia Pharmaceuticals Short Bowel Syndrome Products, Services and Solutions
5.9.4 Naia Pharmaceuticals Short Bowel Syndrome Revenue (US$ Million) & (2018-2023)
5.9.5 Naia Pharmaceuticals Recent Developments
5.10 Zealand Pharma
5.10.1 Zealand Pharma Profile
5.10.2 Zealand Pharma Main Business
5.10.3 Zealand Pharma Short Bowel Syndrome Products, Services and Solutions
5.10.4 Zealand Pharma Short Bowel Syndrome Revenue (US$ Million) & (2018-2023)
5.10.5 Zealand Pharma Recent Developments
6 North America
6.1 North America Short Bowel Syndrome Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Short Bowel Syndrome Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Short Bowel Syndrome Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Short Bowel Syndrome Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Short Bowel Syndrome Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Short Bowel Syndrome Market Dynamics
11.1 Short Bowel Syndrome Industry Trends
11.2 Short Bowel Syndrome Market Drivers
11.3 Short Bowel Syndrome Market Challenges
11.4 Short Bowel Syndrome Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
